"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
…
continue reading
1
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
56:33
56:33
Na później
Na później
Listy
Polub
Polubione
56:33
Vineeta Agarwala, general partner at A16Z's Bio & Health fund, on investing in AI for drug discovery.Autor: Timmerman Report
…
continue reading
1
Ep156: David Liu on New Tools and Techniques for Biology
1:52:57
1:52:57
Na później
Na później
Listy
Polub
Polubione
1:52:57
David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.Autor: Timmerman Report
…
continue reading
1
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's
1:02:37
1:02:37
Na później
Na później
Listy
Polub
Polubione
1:02:37
Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.Autor: Timmerman Report
…
continue reading
1
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
1:03:14
1:03:14
Na później
Na później
Listy
Polub
Polubione
1:03:14
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.Autor: Timmerman Report
…
continue reading
1
Ep153: Rick Young on Studying Gene Expression for Drug Discovery
1:01:43
1:01:43
Na później
Na później
Listy
Polub
Polubione
1:01:43
Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.Autor: Timmerman Report
…
continue reading
1
Ep152: Jens Eckstein on Investing in Healthy Aging
1:05:05
1:05:05
Na później
Na później
Listy
Polub
Polubione
1:05:05
Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.Autor: Timmerman Report
…
continue reading
1
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
1:03:55
1:03:55
Na później
Na później
Listy
Polub
Polubione
1:03:55
Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.Autor: Timmerman Report
…
continue reading
1
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
1:03:48
1:03:48
Na później
Na później
Listy
Polub
Polubione
1:03:48
Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery.Autor: Timmerman Report
…
continue reading
1
Ep149: Nancy Stagliano on Precision Neuroscience
1:01:53
1:01:53
Na później
Na później
Listy
Polub
Polubione
1:01:53
Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery.Autor: Timmerman Report
…
continue reading
1
Ep148: Diana Brainard on the Fight Against Infectious Disease
1:03:27
1:03:27
Na później
Na później
Listy
Polub
Polubione
1:03:27
Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases.Autor: Timmerman Report
…
continue reading
1
Ep147: Reid Huber on Investing in the Future of Medicine
1:08:41
1:08:41
Na później
Na później
Listy
Polub
Polubione
1:08:41
Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine.Autor: Timmerman Report
…
continue reading
1
Ep146: Jeff Huber on Life in Tech and Biotech
1:47:05
1:47:05
Na później
Na później
Listy
Polub
Polubione
1:47:05
Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.Autor: Timmerman Report
…
continue reading
1
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer
1:06:39
1:06:39
Na później
Na później
Listy
Polub
Polubione
1:06:39
Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.Autor: Timmerman Report
…
continue reading
1
Ep144: Turning the Tables, Rob Perez Interviews Me
1:04:58
1:04:58
Na później
Na później
Listy
Polub
Polubione
1:04:58
Turning the Tables, Rob Perez Interviews MeAutor: Timmerman Report
…
continue reading
1
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders
1:10:25
1:10:25
Na później
Na później
Listy
Polub
Polubione
1:10:25
Zach Weinberg and Alexis Borisy of Curie.Bio on Freeing the Biotech FoundersAutor: Timmerman Report
…
continue reading
1
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be
55:54
55:54
Na później
Na później
Listy
Polub
Polubione
55:54
Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.Autor: Timmerman Report
…
continue reading
1
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets
1:09:30
1:09:30
Na później
Na później
Listy
Polub
Polubione
1:09:30
Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.Autor: Timmerman Report
…
continue reading
1
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
1:02:40
1:02:40
Na później
Na później
Listy
Polub
Polubione
1:02:40
Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.Autor: Timmerman Report
…
continue reading
1
Ep139: Kevin Conroy on Early Detection of Cancer
1:08:28
1:08:28
Na później
Na później
Listy
Polub
Polubione
1:08:28
Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.Autor: Timmerman Report
…
continue reading
1
Ep138: Jodie Morrison on Becoming a Biotech CEO
1:00:17
1:00:17
Na później
Na później
Listy
Polub
Polubione
1:00:17
Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.Autor: Timmerman Report
…
continue reading
1
Ep137: Aaron Ring on Immunotherapy for Cancer & More
56:37
56:37
Na później
Na później
Listy
Polub
Polubione
56:37
Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.Autor: Timmerman Report
…
continue reading
1
Ep136: Deborah Palestrant on Building Biotech Startups
52:52
52:52
Na później
Na później
Listy
Polub
Polubione
52:52
Deborah Palestrant, partner at 5AM Ventures and head of the 4:59 initiative, on building biotech startups.Autor: Timmerman Report
…
continue reading
1
Ep135: John Maraganore on Developing a New Class of Medicines
1:03:51
1:03:51
Na później
Na później
Listy
Polub
Polubione
1:03:51
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.Autor: Timmerman Report
…
continue reading
1
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
1:16:22
1:16:22
Na później
Na później
Listy
Polub
Polubione
1:16:22
Emile Nuwaysir, CEO of Boston-based Ensoma, on developing off-the-shelf in vivo gene editing therapies.Autor: Timmerman Report
…
continue reading
1
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
1:10:33
1:10:33
Na później
Na później
Listy
Polub
Polubione
1:10:33
Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.Autor: Timmerman Report
…
continue reading
1
Ep132: Eric Dobmeier on Treating Kidney Disease
1:05:44
1:05:44
Na później
Na później
Listy
Polub
Polubione
1:05:44
Eric Dobmeier, CEO of Seattle-based Chinook Therapeutics, on new strategies for treating kidney diseases.Autor: Timmerman Report
…
continue reading
1
Ep131: Ryan Watts on Neuroscience Drug R&D
1:05:32
1:05:32
Na później
Na później
Listy
Polub
Polubione
1:05:32
Ryan Watts, CEO of South San Francisco-based Denali Therapeutics, on neuroscience drug discovery and development.Autor: Timmerman Report
…
continue reading
1
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave
1:09:29
1:09:29
Na później
Na później
Listy
Polub
Polubione
1:09:29
David Hallal, CEO of ElevateBio, on a long career in biotech and the coming 50-year opportunity in cell therapy and gene therapy.Autor: Timmerman Report
…
continue reading
1
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
1:11:43
1:11:43
Na później
Na później
Listy
Polub
Polubione
1:11:43
Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.Autor: Timmerman Report
…
continue reading
1
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last
1:00:34
1:00:34
Na później
Na później
Listy
Polub
Polubione
1:00:34
Rick Berke, co-founder and executive editor of STAT, on building a biotech journalism outlet to last.Autor: Timmerman Report
…
continue reading
1
Ep127: Jeb Keiper on Computational Drug Discovery
1:09:41
1:09:41
Na później
Na później
Listy
Polub
Polubione
1:09:41
Jeb Keiper, CEO of Nimbus Therapeutics, on computational drug discovery, an unusual business model, and an important new Tyk2 inhibitor for psoriasis and other forms of autoimmunity.Autor: Timmerman Report
…
continue reading
1
Ep126: DA Wallach on Becoming a Biotech VC
1:11:38
1:11:38
Na później
Na później
Listy
Polub
Polubione
1:11:38
DA Wallach, founder and general partner of TIME Bioventures, on becoming a biotech venture investor.Autor: Timmerman Report
…
continue reading
1
Ep125: Barry Greene on a New Drug for Depression
1:04:52
1:04:52
Na później
Na później
Listy
Polub
Polubione
1:04:52
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.Autor: Timmerman Report
…
continue reading
1
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines
1:09:53
1:09:53
Na później
Na później
Listy
Polub
Polubione
1:09:53
Shehnaaz Suliman, CEO of ReCode Therapeutics, on lipid nanoparticle delivery of genetic medicines.Autor: Timmerman Report
…
continue reading
1
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
1:15:26
1:15:26
Na później
Na później
Listy
Polub
Polubione
1:15:26
Tariq Kassum, CEO of Cambridge, Mass.-based Celsius Therapeutics, on using single cell technology for drug discovery.Autor: Timmerman Report
…
continue reading
1
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
1:00:04
1:00:04
Na później
Na później
Listy
Polub
Polubione
1:00:04
Aetna Wun Trombley, CEO of Lycia Therapeutics, on extracellular protein degraders.Autor: Timmerman Report
…
continue reading
1
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
1:03:49
1:03:49
Na później
Na później
Listy
Polub
Polubione
1:03:49
Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.Autor: Timmerman Report
…
continue reading
1
Ep120: Tim Lu on Gene Circuits for Cell Therapy
1:04:14
1:04:14
Na później
Na później
Listy
Polub
Polubione
1:04:14
Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.Autor: Timmerman Report
…
continue reading
1
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
1:02:42
1:02:42
Na później
Na później
Listy
Polub
Polubione
1:02:42
Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.Autor: Timmerman Report
…
continue reading
1
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
1:08:08
1:08:08
Na później
Na później
Listy
Polub
Polubione
1:08:08
Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.Autor: Timmerman Report
…
continue reading
1
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World
1:01:24
1:01:24
Na później
Na później
Listy
Polub
Polubione
1:01:24
Dr. Sanduk Ruit of the Tilganga Institute in Kathmandu on restoring eyesight with affordable cataract surgery for the developing world.Autor: Timmerman Report
…
continue reading
1
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience
58:35
58:35
Na później
Na później
Listy
Polub
Polubione
58:35
Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, on precision neuroscience drug development.Autor: Timmerman Report
…
continue reading
1
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
59:21
59:21
Na później
Na później
Listy
Polub
Polubione
59:21
Rahul Singhvi, CEO of Resilience, on rethinking the model for manufacturing of advanced biologics, gene and cell therapies.Autor: Timmerman Report
…
continue reading
1
Ep114: Chris Gibson on Industrializing Drug Discovery
1:06:33
1:06:33
Na później
Na później
Listy
Polub
Polubione
1:06:33
Chris Gibson, co-founder and CEO of Recursion, on using new tools to industrialize drug discovery.Autor: Timmerman Report
…
continue reading
1
Ep113: Lewis Cantley & Siddhartha Mukherjee on Fighting Cancer with Food and Drugs
40:07
40:07
Na później
Na później
Listy
Polub
Polubione
40:07
Lewis Cantley and Siddhartha Mukherjee, co-founders of Faeth Therapeutics, on fighting cancer with food and drug combinations.Autor: Timmerman Report
…
continue reading
1
Ep112: Bernat Olle on Microbiome Therapeutics
1:06:26
1:06:26
Na później
Na później
Listy
Polub
Polubione
1:06:26
Bernat Olle, CEO of Vedanta Biosciences, on developing microbiome therapeutics.Autor: Timmerman Report
…
continue reading
1
Ep111: Ray Stevens on Structural Biology-Driven Drug Discovery
1:02:42
1:02:42
Na później
Na później
Listy
Polub
Polubione
1:02:42
Ray Stevens, CEO of ShouTi, on structural biology driven drug discovery.Autor: Timmerman Report
…
continue reading
1
Ep110: Michele Andrasik on Making Clinical Trials More Diverse
1:07:25
1:07:25
Na później
Na później
Listy
Polub
Polubione
1:07:25
Michele Andrasik, a clinical health psychologist at the Fred Hutchinson Cancer Research Center, on improving community outreach and diversity in clinical trials.Autor: Timmerman Report
…
continue reading
1
Ep109: Derrell Porter on Cell Therapy Commercialization
1:08:52
1:08:52
Na później
Na później
Listy
Polub
Polubione
1:08:52
Derrell Porter, CEO of CellEvolve, on a new approach to commercializing cell therapies.Autor: Timmerman Report
…
continue reading
1
Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules
1:11:26
1:11:26
Na później
Na później
Listy
Polub
Polubione
1:11:26
Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.Autor: Timmerman Report
…
continue reading